ABC12: New drug kills metastatic melanoma
UC research looks at new drug that could improve treatments for metastatic melanoma
Doctors can often detect and treat early-stage melanoma, but when it advances, it is much tougher to fight and is fatal nearly half the time. Now a team of scientists at the University of Cincinnati is developing a combination therapy that can improve existing melanoma treatments.
Years of sun exposure or other UV light is a risk factor for melanoma, which can be deadly if not caught early.
“Melanoma, eventually, tends to go to the brain,” described Soma Sengupta, MD, PhD, a neuro-oncologist at the University of Cincinnati and UC Health.
“When it goes to the brain, it’s extremely challenging to treat,” explained Daniel Pomeranz Krummel, PhD, a researcher at the University of Cincinnati.
Read more about this research on UC News.
Featured photo of Pomeranz Krummel and Sengupta in their lab by Joe Fuqua/UC Creative + Brand.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up to date on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Mural by UC grad honors U.S. military history
July 17, 2024
Local 12 highlighted a new mural by University of Cincinnati graduate and artist Brandon Hawkins that pays tribute to U.S. military history.
Social media fuels extreme political rhetoric
July 17, 2024
UC College of Arts and Sciences Professor Jeffrey Blevins tells Local 12 that online algorithms fuel political polarization on social media.
From intern to full-time: Recent Lighting Design grad joins...
July 16, 2024
Lighting & Sound America spotlights recent graduate Riley Rowan's new position at Bandit Lites, a full-service design, management and producer of live events and entertainment.